Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Vertice Pharma LLC currently manages 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This matter is assigned to 1 distinct art unit, indicating a concentrated technical scope for the company's current filings. This focused assignment allows the applicant to address the specific examination guidelines of 1 specialized technical division.
The busiest examiner for this portfolio is SMITH, PETER DANIEL, who is responsible for the 1 pending office action. With only 1 distinct examiner involved, the company's current patent efforts are focused on a single point of contact at the office. This direct engagement with SMITH, PETER DANIEL simplifies the prosecution process by centralizing all active claim discussions under 1 official.
Because there is only 1 pending office action, the company's immediate intellectual property goals are concentrated on the outcome of this 1 proceeding. The 1 distinct art unit involved ensures a consistent administrative environment for the review of these medical device innovations. Practitioners should focus on the specific feedback from the 1 assigned examiner to facilitate a successful conclusion to the prosecution.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SMITH, PETER DANIEL | 1 | 50.6% | +51.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18570437 | ADAPTER FOR CLINICAL, MEDICAL AND LABORATORY CONTAINERS | SMITH, PETER DANIEL | 31d overdue |
| Art Unit | Apps |
|---|---|
| 3781 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18570437 | ADAPTER FOR CLINICAL, MEDICAL AND LABORATORY CONTAINERS | SMITH, PETER DANIEL | 3781 | §103 | Final Rejection | 31d overdue | Pending | Dec 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial